Skip to Content Facebook Feature Image

India's leading healthcare network Manipal Hospitals welcomes India's leading cancer specialist Dr. Surender Kumar Dabas to strengthen robotic cancer care in Delhi NCR

Business

India's leading healthcare network Manipal Hospitals welcomes India's leading cancer specialist Dr. Surender Kumar Dabas to strengthen robotic cancer care in Delhi NCR
Business

Business

India's leading healthcare network Manipal Hospitals welcomes India's leading cancer specialist Dr. Surender Kumar Dabas to strengthen robotic cancer care in Delhi NCR

2025-08-18 18:23 Last Updated At:18:45

NEW DELHI, Aug. 18, 2025 /PRNewswire/ -- Manipal Hospitals, one of India's leading and globally recognized healthcare institutions, welcomes one of India's most renowned robotic oncosurgeons, Dr. Surender Kumar Dabas as Chairman – Manipal Comprehensive Cancer Centre and Onco Robotic Surgeries, North-West Cluster. With this addition, the hospital across Delhi, Gurugram and Ghaziabad further reinforces its vision to be a destination for world-class cancer care, catering to patients across India as well as international geographies.

Dr. Surender Dabas brings with him more than 22 years of experience in surgical oncology and has been a pioneer in the field of robotic head and neck cancer surgery. Over the years, he has performed over 30,000 cancer surgeries, including more than 4,000 robot-assisted procedures, making him one of the most experienced robotic oncosurgeons in India. His expertise spans robot-assisted surgeries for head and neck cancer, thoracic cancer, gynaecologic malignancies, urological cancer, gastrointestinal and colorectal cancer, and breast cancer.

Welcoming the doctor, Mr. Pramod Alagharu, Regional COO North-West Cluster, Manipal Hospitals, said, "We are proud to welcome Dr. Surender Dabas and his strong team of 150 medical experts. With his specialized expertise in managing complex cancer procedures, Dr. Dabas brings immense value to our commitment to delivering world-class healthcare, including robot-assisted cancer treatment. His leadership will strengthen our role as a preferred destination for complex oncology cases for both domestic and international patients."

Speaking about his new role, Dr. Surender Kumar Dabas, Chairman - Manipal Comprehensive Cancer Centre and Onco Robotic Surgeries, North-West Cluster added, "I am excited to join the Manipal family, one of the largest healthcare networks in India, which has a long-standing reputation for excellence in healthcare. My goal is to build on a strong foundation here and bring the most advanced and precise cancer care to both national and international patients. Through the use of robotics and newer technologies, we aim to make surgeries safer, less invasive, and more effective, improving both survival and quality of life for our patients."

With Dr. Dabas leading the Manipal Comprehensive Cancer Centre, the hospital is poised to emerge as a centre of excellence in comprehensive cancer care, offering advanced clinical protocols, evidence-based treatment, and a multidisciplinary approach to managing cancer. This will further position Manipal Hospitals as a trusted partner for international patients seeking high-quality, technology-led cancer treatment in India.

For any inquiries, contact our team at query.mhd@manipalhospitals.com or call us +91 8527388881.

About Manipal Hospitals

As a pioneer in healthcare, Manipal Hospitals is among the top healthcare providers in India serving over 7 million patients annually. Its focus is to develop an affordable, high-quality healthcare framework through its multispecialty and tertiary care delivery spectrum and further extend it to out-of-hospital care. With the completion of the acquisition of Medica Synergie hospitals and AMRI Hospitals Limited (acquired in Sept 2023), the integrated network today has a pan-India footprint of 38 hospitals across 19 cities with 10,500+ beds and a talented pool of 7,200+ doctors and an employee strength of over 20,500.

Manipal Hospitals provides comprehensive curative and preventive care for a multitude of patients from around the globe. Manipal Hospitals is NABH and AAHRPP accredited, and most of the hospitals in its network are NABL, ER, and Blood Bank accredited and recognized for Nursing Excellence. Manipal Hospitals has also been recognized as the most respected and patient-recommended hospital in India through various consumer surveys.

 

NEW DELHI, Aug. 18, 2025 /PRNewswire/ -- Manipal Hospitals, one of India's leading and globally recognized healthcare institutions, welcomes one of India's most renowned robotic oncosurgeons, Dr. Surender Kumar Dabas as Chairman – Manipal Comprehensive Cancer Centre and Onco Robotic Surgeries, North-West Cluster. With this addition, the hospital across Delhi, Gurugram and Ghaziabad further reinforces its vision to be a destination for world-class cancer care, catering to patients across India as well as international geographies.

Dr. Surender Dabas brings with him more than 22 years of experience in surgical oncology and has been a pioneer in the field of robotic head and neck cancer surgery. Over the years, he has performed over 30,000 cancer surgeries, including more than 4,000 robot-assisted procedures, making him one of the most experienced robotic oncosurgeons in India. His expertise spans robot-assisted surgeries for head and neck cancer, thoracic cancer, gynaecologic malignancies, urological cancer, gastrointestinal and colorectal cancer, and breast cancer.

Welcoming the doctor, Mr. Pramod Alagharu, Regional COO North-West Cluster, Manipal Hospitals, said, "We are proud to welcome Dr. Surender Dabas and his strong team of 150 medical experts. With his specialized expertise in managing complex cancer procedures, Dr. Dabas brings immense value to our commitment to delivering world-class healthcare, including robot-assisted cancer treatment. His leadership will strengthen our role as a preferred destination for complex oncology cases for both domestic and international patients."

Speaking about his new role, Dr. Surender Kumar Dabas, Chairman - Manipal Comprehensive Cancer Centre and Onco Robotic Surgeries, North-West Cluster added, "I am excited to join the Manipal family, one of the largest healthcare networks in India, which has a long-standing reputation for excellence in healthcare. My goal is to build on a strong foundation here and bring the most advanced and precise cancer care to both national and international patients. Through the use of robotics and newer technologies, we aim to make surgeries safer, less invasive, and more effective, improving both survival and quality of life for our patients."

With Dr. Dabas leading the Manipal Comprehensive Cancer Centre, the hospital is poised to emerge as a centre of excellence in comprehensive cancer care, offering advanced clinical protocols, evidence-based treatment, and a multidisciplinary approach to managing cancer. This will further position Manipal Hospitals as a trusted partner for international patients seeking high-quality, technology-led cancer treatment in India.

For any inquiries, contact our team at query.mhd@manipalhospitals.com or call us +91 8527388881.

About Manipal Hospitals

As a pioneer in healthcare, Manipal Hospitals is among the top healthcare providers in India serving over 7 million patients annually. Its focus is to develop an affordable, high-quality healthcare framework through its multispecialty and tertiary care delivery spectrum and further extend it to out-of-hospital care. With the completion of the acquisition of Medica Synergie hospitals and AMRI Hospitals Limited (acquired in Sept 2023), the integrated network today has a pan-India footprint of 38 hospitals across 19 cities with 10,500+ beds and a talented pool of 7,200+ doctors and an employee strength of over 20,500.

Manipal Hospitals provides comprehensive curative and preventive care for a multitude of patients from around the globe. Manipal Hospitals is NABH and AAHRPP accredited, and most of the hospitals in its network are NABL, ER, and Blood Bank accredited and recognized for Nursing Excellence. Manipal Hospitals has also been recognized as the most respected and patient-recommended hospital in India through various consumer surveys.

 

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

India's leading healthcare network Manipal Hospitals welcomes India's leading cancer specialist Dr. Surender Kumar Dabas to strengthen robotic cancer care in Delhi NCR

India's leading healthcare network Manipal Hospitals welcomes India's leading cancer specialist Dr. Surender Kumar Dabas to strengthen robotic cancer care in Delhi NCR

PANAMA CITY, Jan. 29, 2026 /PRNewswire/ -- Recently, HTX Ventures, the global investment arm of HTX, released its latest research report, 2025 Annual Review: Crypto Assets Move Toward Mainstream Adoption. As long-term participants deeply embedded in the industry, HTX and HTX Ventures remain focused on building foundational capabilities that endure across market cycles. On one hand, HTX Ventures tracks structural trends through rigorous research to identify the market's long-term direction. Through investment and ecosystem collaboration, it supports teams with tangible product strength and sustainable business models, advancing the integration of crypto technology into broader real-world use cases in a more resilient and sustainable manner.

Regulation Becomes Predictable: Clear Rules Drawing Institutional Capital In

HTX Ventures notes that in 2025, regulatory ambiguity across major global jurisdictions narrowed significantly. Moving from a phase of grey-zone tolerance to one of formal rule-setting, regulators focus on stablecoin frameworks, market structure compliance, and stricter requirements for trading, custody, and disclosure. In the United States, the GENIUS Act established a federal-level framework for payment stablecoins, reinforcing requirements such as full 1:1 reserve backing. In Europe, the implementation of MiCA has materially raised compliance thresholds, pushing the industry from growth-at-all-costs toward compliant competition. Hong Kong, meanwhile, has advanced its stablecoin regulatory regime through issuer licensing frameworks and the rollout of new rules.

Everything On-Chain: Stablecoin Payments and RWA Tokenization Entering an Expansion Phase

In 2025, two forces jointly reshaped on-chain infrastructure: the expansion of stablecoins and the institutional adoption of RWA tokens.

Stablecoins accelerated their evolution from crypto-native tools into global financial infrastructure. Total stablecoin market capitalization reached a record high of $308 billion in Oct. 2025 and stabilized around $309.4 billion by mid-Dec. representing a 50.3% increase over the year. Annual on-chain transaction volume exceeded $46 trillion, comparable to the combined annual volumes of Visa, Mastercard, and PayPal.

The RWA tokenization market entered a phase of accelerated growth. As of Dec. 17, 2025, the total value of on-chain distributed RWA assets (excluding stablecoins) reached $18.74 billion, more than tripling since the beginning of the year. Tokenized U.S. Treasuries reached approximately 8.7 billion, accounting for 47.3%, with landmark products such as BlackRock's BUIDL (approximately $2.006 billion). This exemplifies deeper integration between traditional asset management and on-chain tokenization.

Clearer Institutional Entry Paths: From "Whether to Allocate" to "How to Allocate Compliantly"

HTX Ventures characterizes 2025 as the year when institutional adoption pathways became quantifiable. The core shift was not institutions broadly betting on high-volatility assets, but rather entering the crypto space through more auditable, standardized structures aligned with traditional balance sheet frameworks, decomposing on-chain capabilities into deployable financial modules.

Institutional participation is advancing through several well-defined paths: gaining crypto exposure through ETFs and ETPs; incorporating BTC into corporate treasuries; migrating payments and settlement on-chain via stablecoins; and transforming cash equivalents and collateral into composable on-chain assets through RWA tokenization.

Crucially, institutional participation is changing how the market functions. HTX Ventures summarizes these structural effects in three areas:

  1. Rising market concentration as capital gravitates toward major assets.
  2. Emphasis on compliance and risk management, with increased demands for data transparency.
  3. Pricing and yield curves that increasingly resemble traditional finance, incorporating concepts such as term structure and funding costs.

Strategically, institutions favor low-risk, medium-yield strategies—such as arbitrage, market making, and delta-neutral hedging—acting as structure providers rather than short-term price drivers.

HTX Ventures' Focus Areas for 2026

Alec, Head of HTX Ventures, commented: "After the structural shifts of 2025, the industry is entering a critical phase defined by infrastructure competition. Capital is flowing in along pathways that are regulated, auditable, and scalable. As a result, the next phase will be less about short-term price performance and more about which players can continuously accumulate value at the infrastructure layer."

Building upon the trends, HTX Ventures will focus on the following areas in 2026:

  • AI x Blockchain: AI agent frameworks, machine accounts and payments, on-chain execution automation, and closed-loop data pricing and settlement
  • Stablecoins and Payment Infrastructure: Compliant issuance and reserve management, on-chain settlement and reconciliation, risk management and AML, enterprise-grade wallet permissions, and payment routing optimization
  • RWA Tokenization Expansion and Secondary Liquidity: Tokenization of cash equivalents, private credit, and institutional assets; the development of trading and liquidity infrastructure
  • User Experience and Productization: Applications and protocols that lower barriers to on-chain finance through improved interaction, one-click cross-chain functionality, and mobile security
  • Multi-chain Application Ecosystem: Identifying strong applications and integrated platforms that can retain users, cash flows, and developers in a multi-chain environment

In 2026, HTX and HTX Ventures will keep pursuing value creation with longtermism, focusing on critical infrastructure and real-world use cases, and advancing crypto technology adoption toward a more open, fair, and transparent global financial system.

About HTX Ventures

HTX Ventures is the global investment arm of HTX, integrating investment, incubation, and research to identify and discover the best and most innovative projects in the market. Visit us here.

PANAMA CITY, Jan. 29, 2026 /PRNewswire/ -- Recently, HTX Ventures, the global investment arm of HTX, released its latest research report, 2025 Annual Review: Crypto Assets Move Toward Mainstream Adoption. As long-term participants deeply embedded in the industry, HTX and HTX Ventures remain focused on building foundational capabilities that endure across market cycles. On one hand, HTX Ventures tracks structural trends through rigorous research to identify the market's long-term direction. Through investment and ecosystem collaboration, it supports teams with tangible product strength and sustainable business models, advancing the integration of crypto technology into broader real-world use cases in a more resilient and sustainable manner.

Regulation Becomes Predictable: Clear Rules Drawing Institutional Capital In

HTX Ventures notes that in 2025, regulatory ambiguity across major global jurisdictions narrowed significantly. Moving from a phase of grey-zone tolerance to one of formal rule-setting, regulators focus on stablecoin frameworks, market structure compliance, and stricter requirements for trading, custody, and disclosure. In the United States, the GENIUS Act established a federal-level framework for payment stablecoins, reinforcing requirements such as full 1:1 reserve backing. In Europe, the implementation of MiCA has materially raised compliance thresholds, pushing the industry from growth-at-all-costs toward compliant competition. Hong Kong, meanwhile, has advanced its stablecoin regulatory regime through issuer licensing frameworks and the rollout of new rules.

Everything On-Chain: Stablecoin Payments and RWA Tokenization Entering an Expansion Phase

In 2025, two forces jointly reshaped on-chain infrastructure: the expansion of stablecoins and the institutional adoption of RWA tokens.

Stablecoins accelerated their evolution from crypto-native tools into global financial infrastructure. Total stablecoin market capitalization reached a record high of $308 billion in Oct. 2025 and stabilized around $309.4 billion by mid-Dec. representing a 50.3% increase over the year. Annual on-chain transaction volume exceeded $46 trillion, comparable to the combined annual volumes of Visa, Mastercard, and PayPal.

The RWA tokenization market entered a phase of accelerated growth. As of Dec. 17, 2025, the total value of on-chain distributed RWA assets (excluding stablecoins) reached $18.74 billion, more than tripling since the beginning of the year. Tokenized U.S. Treasuries reached approximately 8.7 billion, accounting for 47.3%, with landmark products such as BlackRock's BUIDL (approximately $2.006 billion). This exemplifies deeper integration between traditional asset management and on-chain tokenization.

Clearer Institutional Entry Paths: From "Whether to Allocate" to "How to Allocate Compliantly"

HTX Ventures characterizes 2025 as the year when institutional adoption pathways became quantifiable. The core shift was not institutions broadly betting on high-volatility assets, but rather entering the crypto space through more auditable, standardized structures aligned with traditional balance sheet frameworks, decomposing on-chain capabilities into deployable financial modules.

Institutional participation is advancing through several well-defined paths: gaining crypto exposure through ETFs and ETPs; incorporating BTC into corporate treasuries; migrating payments and settlement on-chain via stablecoins; and transforming cash equivalents and collateral into composable on-chain assets through RWA tokenization.

Crucially, institutional participation is changing how the market functions. HTX Ventures summarizes these structural effects in three areas:

Strategically, institutions favor low-risk, medium-yield strategies—such as arbitrage, market making, and delta-neutral hedging—acting as structure providers rather than short-term price drivers.

HTX Ventures' Focus Areas for 2026

Alec, Head of HTX Ventures, commented: "After the structural shifts of 2025, the industry is entering a critical phase defined by infrastructure competition. Capital is flowing in along pathways that are regulated, auditable, and scalable. As a result, the next phase will be less about short-term price performance and more about which players can continuously accumulate value at the infrastructure layer."

Building upon the trends, HTX Ventures will focus on the following areas in 2026:

  • AI x Blockchain: AI agent frameworks, machine accounts and payments, on-chain execution automation, and closed-loop data pricing and settlement
  • Stablecoins and Payment Infrastructure: Compliant issuance and reserve management, on-chain settlement and reconciliation, risk management and AML, enterprise-grade wallet permissions, and payment routing optimization
  • RWA Tokenization Expansion and Secondary Liquidity: Tokenization of cash equivalents, private credit, and institutional assets; the development of trading and liquidity infrastructure
  • User Experience and Productization: Applications and protocols that lower barriers to on-chain finance through improved interaction, one-click cross-chain functionality, and mobile security
  • Multi-chain Application Ecosystem: Identifying strong applications and integrated platforms that can retain users, cash flows, and developers in a multi-chain environment

In 2026, HTX and HTX Ventures will keep pursuing value creation with longtermism, focusing on critical infrastructure and real-world use cases, and advancing crypto technology adoption toward a more open, fair, and transparent global financial system.

About HTX Ventures

HTX Ventures is the global investment arm of HTX, integrating investment, incubation, and research to identify and discover the best and most innovative projects in the market. Visit us here.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

HTX Ventures Annual Review and Outlook: Regulatory Clarity, Asset Tokenization, and Institutional Adoption Resonate

HTX Ventures Annual Review and Outlook: Regulatory Clarity, Asset Tokenization, and Institutional Adoption Resonate

Recommended Articles